Trakshel G M, Kutty R K, Maines M D
Arch Biochem Biophys. 1986 Nov 15;251(1):175-87. doi: 10.1016/0003-9861(86)90064-0.
The concerted activity of two microsomal enzymes, heme oxygenase and NADPH-cytochrome c (P-450) reductase, is required for isomer-specific oxidation of heme molecule; heme oxygenase is commonly believed to be rate limiting in this activity. In this report, we provide evidence strongly suggesting the rate-limiting role of the reductase in oxidation of heme molecule in rat testis. In the testis and the liver of rats treated with Cd (20 mumol/kg, sc, 24 h) heme oxygenase activity, assessed by the formation of bilirubin, was decreased by 50% and increased by 7-fold, respectively. In these animals, the reductase activity was decreased by nearly 75% in the testis, but remained unchanged in the liver. Similarly, the reductase activity in the liver was not altered when heme oxygenase activity was increased by 20-fold in response to bromobenzene treatment. Addition of purified testicular reductase preparation (purified over 4000-fold), or hepatic reductase, to the testicular microsomes of Cd-treated rats obliterated the Cd-mediated inhibition of heme oxygenase activity. The chromatographic separation of heme oxygenase and the reductase of the testicular microsomal fractions revealed that the reductase activity was markedly decreased (75%) while the heme oxygenase activity, when assessed in the presence of exogenous reductase, was not affected by in vivo Cd treatment. In vitro, the membrane-bound reductase preparation obtained from the testis was more sensitive to the inhibitory effect of Cd than the liver preparation. However, the purified reductase preparations from the testis and the liver exhibited a similar degree of sensitivity to Cd. Based on the molar ratio of heme oxygenase to the reductase in the microsomal membranes of the liver and the testis it appeared that the testicular heme oxygenase, which is predominantly HO-2 isoform, interacts with the reductase less effectively than HO-1; in the induced liver, heme oxygenase is predominantly the HO-1 isoform. It is suggested that due to the low abundance of NADPH-cytochrome c (P-450) reductase and the apparently lower affinity of the enzyme for HO-2, the reductase exerts a regulatory action on heme oxygenase activity in the testis.
血红素分子的异构体特异性氧化需要两种微粒体酶——血红素加氧酶和NADPH-细胞色素c(P-450)还原酶的协同作用;一般认为血红素加氧酶在该活性中起限速作用。在本报告中,我们提供的证据强烈表明还原酶在大鼠睾丸血红素分子氧化中起限速作用。在用Cd(20 μmol/kg,皮下注射,24小时)处理的大鼠的睾丸和肝脏中,通过胆红素形成评估的血红素加氧酶活性分别降低了50%和增加了7倍。在这些动物中,睾丸中的还原酶活性降低了近75%,但肝脏中的还原酶活性保持不变。同样,当用溴苯处理使血红素加氧酶活性增加20倍时,肝脏中的还原酶活性没有改变。向Cd处理大鼠的睾丸微粒体中添加纯化的睾丸还原酶制剂(纯化超过4000倍)或肝脏还原酶,消除了Cd介导的对血红素加氧酶活性的抑制。睾丸微粒体部分的血红素加氧酶和还原酶的色谱分离显示,还原酶活性显著降低(75%),而在外源还原酶存在下评估时,血红素加氧酶活性不受体内Cd处理的影响。在体外,从睾丸获得的膜结合还原酶制剂比肝脏制剂对Cd的抑制作用更敏感。然而,从睾丸和肝脏纯化的还原酶制剂对Cd的敏感程度相似。根据肝脏和睾丸微粒体膜中血红素加氧酶与还原酶的摩尔比,似乎睾丸中的血红素加氧酶(主要是HO-2同工型)与还原酶的相互作用比HO-1更无效;在诱导的肝脏中,血红素加氧酶主要是HO-1同工型。有人认为,由于NADPH-细胞色素c(P-450)还原酶的丰度较低以及该酶对HO-2的亲和力明显较低,还原酶对睾丸中的血红素加氧酶活性发挥调节作用。